← Mechanisms of action
PDCD1
SINGLE PROTEINHomo sapiens
Preferred name: Programmed cell death protein 1 ChEMBL ↗
Linked proteins
Drugs acting on this target (123)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| gs-0151 | Agonist | experimental | Small molecule | PDCD1 agonist |
| rosnilimab | Agonist | experimental | mAb | PD1 |
| ak105 | Antagonist | experimental | mAb | PD1 |
| AZD2936 | Antagonist | experimental | mAb | PD1 |
| azd7789 | Antagonist | experimental | mAb | PD1 |
| balstilimab | Antagonist | experimental | mAb | PD1 |
| bat1308 | Antagonist | experimental | mAb | PD1 |
| bat7104 | Antagonist | experimental | mAb | PD1 |
| caldonirimab | Antagonist | experimental | mAb | PD1 |
| camrelizumab | Antagonist | experimental | mAb | PDCD1 antagonist |
| dostarlimab (Jemperli) | Antagonist | approved | mAb | Programmed cell death protein 1 antagonist |
| evt801 | Antagonist | experimental | mAb | PD1 |
| hlx10 | Antagonist | experimental | mAb | Programmed cell death protein 1 antagonist |
| HX-008 | Antagonist | experimental | mAb | PD1 |
| IBI319 | Antagonist | experimental | mAb | PD1 |
| ibi321 | Antagonist | experimental | mAb | PD1 |
| inca32459-101 | Antagonist | experimental | mAb | PD1 |
| lb1410 | Antagonist | experimental | mAb | pd1 |
| lbl-015 | Antagonist | experimental | mAb | PD1 |
| lbl-019 | Antagonist | experimental | mAb | PD1 |
| lm-108 | Antagonist | experimental | mAb | PDCD1 antagonist |
| lvgn3616 | Antagonist | experimental | mAb | PD1 |
| palivizumab (Synagis) | Antagonist | approved | mAb | PD1 |
| penpulimab | Antagonist | approved | mAb | PD1 |
| pf-07225570 | Antagonist | experimental | mAb | PD1 |
| retifanlimab (Zynyz) | Antagonist | approved | mAb | PDCD1 antagonist |
| sasanlimab | Antagonist | experimental | mAb | Programmed cell death protein 1 antagonist |
| si-b003 | Antagonist | experimental | mAb | PD1 |
| sintilimab | Antagonist | experimental | mAb | PDCD1 antagonist |
| spartalizumab | Antagonist | experimental | mAb | Programmed cell death protein 1 antagonist |
| ssgj-705 | Antagonist | experimental | mAb | PD1 |
| tirelizumab | Antagonist | experimental | mAb | PD1 |
| toripalimab (LOQTORZ) | Antagonist | approved | mAb | PDCD1 antagonist |
| tqb2868 | Antagonist | experimental | mAb | PD1 |
| zg005 | Antagonist | experimental | mAb | PDCD1 antagonist |
| zimberelimab | Antagonist | experimental | mAb | PD1 |
| ph-762 | Antisense inhibitor | experimental | Nucleic acid | PDCD1 antisense inhibitor |
| imu-201 | Immunity, active | experimental | Vaccine | PDCD1 immunity, active |
| αpd1-msln-car t cells | Immunity, passive | experimental | Cell therapy | PDCD1 immunity, passive |
| 89zr-pembrolizumab | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| ak-104 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| ak112 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| ak131 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| amg 256 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| amp-224 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| anv600 | Inhibitor | experimental | Recombinant protein | PDCD1 inhibitor |
| apl-501 | Inhibitor | experimental | mAb | Programmed cell death protein 1 inhibitor |
| askg915 | Inhibitor | experimental | Recombinant protein | PDCD1 inhibitor |
| awt020 | Inhibitor | experimental | Recombinant protein | PDCD1 inhibitor |
| bc008 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| bcd-217 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| bpt567 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| budigalimab | Inhibitor | experimental | mAb | Programmed cell death protein 1 inhibitor |
| cadonilimab | Inhibitor | experimental | mAb | Programmed cell death protein 1 inhibitor |
| cd-001 | Inhibitor | experimental | Recombinant protein | PDCD1 inhibitor |
| cdx-527 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| cemiplimab (libtayo) | Inhibitor | approved | mAb | Programmed cell death protein 1 inhibitor |
| cetrelimab | Inhibitor | experimental | mAb | Programmed cell death protein 1 inhibitor |
| cm310 | Inhibitor | experimental | mAb | Programmed cell death protein 1 inhibitor |
| copper cu 64-dota-pembrolizumab | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| cr-001 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| cs2009 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| ct011 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| ctx-10726 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| ctx-8371 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| dv281 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| emb-02 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| enlonstobart | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| fp008 | Inhibitor | experimental | Recombinant protein | PDCD1 inhibitor |
| gb268 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| gensci120 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| hbt-708 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| hlx17 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| hx008 | Inhibitor | experimental | mAb | Programmed cell death protein 1 inhibitor |
| hx009 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| iap0971 | Inhibitor | experimental | Recombinant protein | PDCD1 inhibitor |
| ibi315 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| ibi318 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| icon-1 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| inca33890 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| iparomlimab | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| jmt108 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| js201 | Inhibitor | experimental | Recombinant protein | PDCD1 inhibitor |
| js207 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| ky-0118 | Inhibitor | experimental | Recombinant protein | PDCD1 inhibitor |
| lerapolturev | Inhibitor | experimental | Small molecule | PDCD1 inhibitor |
| lm-299 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| lvgn 3616 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| maq-001 | Inhibitor | experimental | Biological | PDCD1 inhibitor |
| medi5752 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| mgd013 | Inhibitor | experimental | mAb | Programmed cell death protein 1 inhibitor |
| mgd019 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| mhb039a | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| nivolumab (opdivo) | Inhibitor | approved | mAb | PDCD1 inhibitor |
| ono-4685 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| ono-7018 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| p1801 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| pd-1/ctla-4 dual functional antibody | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| pe0105 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| pembrolizumab (keytruda) | Inhibitor | approved | mAb | PDCD1 inhibitor |
| penpulimab | Inhibitor | approved | mAb | Programmed cell death protein 1 inhibitor |
| pidilizumab | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| Prolgolimab | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| psb205 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| ql-1706 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| ql1604 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| ql1706 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| regn10597 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| ro7121661 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| ro7247669 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| ro7284755 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| s-4321 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| sar445877 | Inhibitor | experimental | Recombinant protein | PDCD1 inhibitor |
| shr-1901 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| shr-5495 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| sindilizumab | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| sot201 | Inhibitor | experimental | Recombinant protein | PDCD1 inhibitor |
| sysa1802 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| tislelizumab | Inhibitor | approved | mAb | PDCD1 inhibitor |
| xmab20717 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| xmab23104 | Inhibitor | experimental | mAb | PDCD1 inhibitor |
| zimberelimab | Inhibitor | experimental | mAb | Programmed cell death protein 1 inhibitor |
| sl-279252 | Supplementation | experimental | Recombinant protein | PDCD1 supplementation |